New site KCAKidney Cancer pre-press articlesPerioperative Systemic Therapy for Metastatic Renal Cell CarcinomaTherapeutic Sequencing in Metastatic Renal Cell CarcinomaRationale to prime the immune system

We are excited to launch this website for the new IOS Press journal Kidney Cancer. We welcome your feedback at kca@iospress.com. Thank you in advance and enjoy your visit!

Axial, coronal, and sagittal CT images of the patient’s abdomen and pelvis revealing metastatic disease at different time points during his therapy. From: Nakajima et al., Kidney Cancer, vol. 1, no. 1, pp. 83-88, 2017

Renal cell carcinoma`s disease biology: inactivated VHL gene leads to overexpression of HIF. Genes activated by HIF transcript growth factors such as VEGF, PDGF and FGF. From: Maia et al., Kidney Cancer, vol. 1, no. 1, pp. 15-29, 2017

Schematic of early-phase clinical trial for presurgical systemic antiangiogenic therapy in metastatic RCC. From: Pilié and Jonasch, Kidney Cancer, vol. 1, no. 1, pp. 57-64, 2017

Rationale to prime the immune system with PD-1 blockade prior to nephrectomy. From: Harshman et al., Kidney Cancer, vol. 1, no. 1, pp. 31-40, 2017

Welcome to Kidney Cancer

Editorial Board

Primo N. Lara Jr, MD

University of California Davis Comprehensive Cancer Center
Sacramento, CA, USA

Email: kca@iospress.com

Peter Mulders, MD, PhD

Radboud UMC Nijmegen,The Netherlands

Email: kca@iospress.com

 

Submission Guidelines

SUBMIT YOUR MANUSCRIPT HERE

SUBMISSION OF MANUSCRIPTS:

AUTHOR INSTRUCTIONS

Authors are requested to submit their manuscript electronically to the online submission system msTracker. Note that the manuscript should be uploaded as one file with tables and figures included.

Tweets

No front page content has been created yet.